Erste Asset Management GmbH Raises Stake in Masimo Corporation $MASI

Erste Asset Management GmbH boosted its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 25.0% in the fourth quarter, HoldingsChannel reports. The fund owned 200,000 shares of the medical equipment provider’s stock after acquiring an additional 40,000 shares during the period. Erste Asset Management GmbH’s holdings in Masimo were worth $26,012,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. O Shaughnessy Asset Management LLC lifted its position in Masimo by 18.1% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 1,762 shares of the medical equipment provider’s stock valued at $229,000 after acquiring an additional 270 shares during the period. CenterBook Partners LP purchased a new position in Masimo during the 4th quarter valued at about $409,000. JPMorgan Chase & Co. lifted its position in Masimo by 9.1% during the 4th quarter. JPMorgan Chase & Co. now owns 117,798 shares of the medical equipment provider’s stock valued at $15,321,000 after acquiring an additional 9,857 shares during the period. Los Angeles Capital Management LLC purchased a new position in Masimo during the 4th quarter valued at about $31,000. Finally, Havemeyer Place LP purchased a new position in Masimo during the 4th quarter valued at about $393,000. 85.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Piper Sandler cut shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target for the company. in a research report on Tuesday, February 17th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Finally, Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a research note on Tuesday, February 17th. Nine equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $180.40.

Masimo Price Performance

NASDAQ:MASI opened at $178.82 on Monday. The firm has a market cap of $9.36 billion, a P/E ratio of -16.97, a P/E/G ratio of 1.81 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. Masimo Corporation has a fifty-two week low of $125.94 and a fifty-two week high of $179.00. The firm has a 50-day simple moving average of $178.45 and a two-hundred day simple moving average of $159.41.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.